Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DE-110 in Dry Eye Disease
NCT01239069Phase 2Completed
- Sponsor
- Santen Pharmaceutical
- Start
- Nov 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DE-110 in dry eye disease (DED), sponsored by Santen Pharmaceutical. Started Nov 2010; status: completed.
02
Drugs
DE-110
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT01239069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01239069.